Evidence map›Paper›PMID 28289210›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Phosphorylation-induced conformational dynamics in an intrinsically disordered protein and potential role in phenotypic heterogeneity.

Prakash Kulkarni, Mohit Kumar Jolly, Dongya Jia, Steven M Mooney, Ajay Bhargava, Luciane T Kagohara, Yihong Chen, Pengyu Hao, Yanan He, Robert W Veltri and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 89 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Journal of biosciences · 2022
    Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Prakash KulkarniInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850; herbert.levine@rice.edu pkulkar4@ibbr.umd.edu jorban@umd.edu.
Mohit Kumar JollyCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005.
Dongya JiaCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005.
Steven M MooneyDepartment of Biology, University of Waterloo, Waterloo, ON Canada N2L 3G1.
Ajay BhargavaShakti BioResearch, Woodbridge, CT 06525.
Luciane T KagoharaDepartment of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Yihong ChenInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850.
Pengyu HaoDepartment of Physics, North Carolina State University, Raleigh, NC 27695.
Yanan HeInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850.
Robert W VeltriDepartment of Urology, Johns Hopkins University School of Medicine, Baltimore, MD 21287.
Alexander GrishaevInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850.
Keith WeningerDepartment of Physics, North Carolina State University, Raleigh, NC 27695.
Herbert LevineCenter for Theoretical Biological Physics, Rice University, Houston, TX 77005; herbert.levine@rice.edu pkulkar4@ibbr.umd.edu jorban@umd.edu.
John OrbanInstitute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD 20850; herbert.levine@rice.edu pkulkar4@ibbr.umd.edu jorban@umd.edu.
Center for Theoretical Biological Physics · USJohns Hopkins Medicine · USNational Institute of Standards and Technology · USNorth Carolina State University · USUniversity of Maryland, College Park · USRice University · USUniversity of Maryland, Baltimore · USUniversity of Waterloo · CA

Funding

Structure and stability of 3_alpha vs alpha_beta foldsR01GM062154 · NIGMS · UNIV OF MARYLAND, COLLEGE PARK · PI BRYAN, PHILIP N, ORBAN, JOHN · 2002 to 2016
$3.2M
PAGE4 as a Novel Target for Prostate Cancer PreventionR21CA181730 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI KULKARNI, PRAKASH, ORBAN, JOHN · 2014 to 2015
$364k
NCI NIH HHS R21 CA181730NIGMS NIH HHS R01 GM062154
6 · The paper itself

Abstract

Intrinsically disordered proteins (IDPs) that lack a unique 3D structure and comprise a large fraction of the human proteome play important roles in numerous cellular functions. Prostate-Associated Gene 4 (PAGE4) is an IDP that acts as a potentiator of the Activator Protein-1 (AP-1) transcription factor. Homeodomain-Interacting Protein Kinase 1 (HIPK1) phosphorylates PAGE4 at S9 and T51, but only T51 is critical for its activity. Here, we identify a second kinase, CDC-Like Kinase 2 (CLK2), which acts on PAGE4 and hyperphosphorylates it at multiple S/T residues, including S9 and T51. We demonstrate that HIPK1 is expressed in both androgen-dependent and androgen-independent prostate cancer (PCa) cells, whereas CLK2 and PAGE4 are expressed only in androgen-dependent cells. Cell-based studies indicate that PAGE4 interaction with the two kinases leads to opposing functions. HIPK1-phosphorylated PAGE4 (HIPK1-PAGE4) potentiates c-Jun, whereas CLK2-phosphorylated PAGE4 (CLK2-PAGE4) attenuates c-Jun activity. Consistent with the cellular data, biophysical measurements (small-angle X-ray scattering, single-molecule fluorescence resonance energy transfer, and NMR) indicate that HIPK1-PAGE4 exhibits a relatively compact conformational ensemble that binds AP-1, whereas CLK2-PAGE4 is more expanded and resembles a random coil with diminished affinity for AP-1. Taken together, the results suggest that the phosphorylation-induced conformational dynamics of PAGE4 may play a role in modulating changes between PCa cell phenotypes. A mathematical model based on our experimental data demonstrates how differential phosphorylation of PAGE4 can lead to transitions between androgen-dependent and androgen-independent phenotypes by altering the AP-1/androgen receptor regulatory circuit in PCa cells.

Indexed as

Antigens, NeoplasmHumansIntrinsically Disordered ProteinsModels, MolecularPhenotypePhosphorylationProtein ConformationProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProteomeAntigens, NeoplasmClk dual-specificity kinasesIntrinsically Disordered ProteinsPAGE4 protein, humanProtein Serine-Threonine KinasesProtein-Tyrosine KinasesProteomeandrogen resistanceintrinsic disorderPAGE-4phenotypic heterogeneityprostate cancer

Identifiers

PMID28289210
PMCPMC5380051
OpenAlexW2595623539

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.